• E-64d: Practical Workflows for Cysteine Proteases

  2026-09-22

  E-64d combines cell permeability with irreversible cysteine protease inhibition, making it useful for separating calpain- and cathepsin-linked events in intact-cell experiments. This guide translates the reagent into reproducible workflows for apoptosis, lysosomal membrane permeabilization, platelet biology, seizure models, and cancer research while emphasizing controls that prevent overinterpretation.

• SU5416 (Semaxanib) Experimental Workflow Guide

  2026-09-22

  SU5416 (Semaxanib) enables controlled interrogation of VEGFR2-driven endothelial signaling, tumor vascularization, and angiogenic remodeling. This workflow also shows how to connect vascular perturbation experiments with the HGFA biomarker framework reported in pulmonary arterial hypertension research, while separating established evidence from exploratory applications.

• Chenodeoxycholic Acid: FXR Research Workflows

  2026-09-21

  Turn CDCA into a practical probe for FXR-dependent transcription, cholesterol homeostasis, and contrast-induced kidney injury models. This workflow links stock preparation to KLF11, JAK2/STAT3, renal injury, and orthogonal validation while separating evidence-based findings from optimization recommendations.

• BKT140: From CXCR4 Biology to Assay Design

  2026-09-21

  BKT140 and BL-8040 are CXCR4 antagonists with applications spanning tumor biology and hematopoietic stem cell mobilization. This assay-first guide explains how to translate CXCR4 biology into defensible chemotaxis, apoptosis, xenograft, and mobilization workflows.

• Nav1.5 Ser571 Phosphorylation in Cardiac Aging

  2026-09-20

  The 2024 study identifies Nav1.5 phosphorylation at Ser571 as a mechanistic link between increased late sodium current, delayed ventricular repolarization, and impaired diastolic relaxation during cardiac aging. By comparing wild-type, gain-of-function, and loss-of-function mice, it shows that late INa is not merely associated with aging-related dysfunction but helps shape its electrical and mechanical phenotype.

• ECM1 Epitope LA as a Dual-Immune Tumor Vaccine

  2026-09-19

  Yu et al. identified the HLA-A2.1-restricted ECM1-derived epitope LA as a candidate therapeutic vaccine that activates both CD8+ T cells and NK cells through dendritic-cell cross-activation. The study combines epitope discovery, human immune-cell assays, mechanistic pathway analysis, and tumor-bearing mouse models to support a dual adaptive–innate antitumor strategy.

• BKT140 (BL-8040) CXCR4 Research Workflows

  2026-09-18

  BKT140, also known as BL-8040, enables integrated studies of CXCR4-driven migration, tumor–microenvironment interactions, apoptosis, and stem cell mobilization. This workflow-focused guide connects receptor pharmacology with assay design, formulation control, and translational interpretation.

• 2X HyperFusion™ High-Fidelity PCR for CRISPR

  2026-09-18

  The 2X HyperFusion High-Fidelity Master Mix supports accurate, reproducible DNA amplification for CRISPR nanomedicine workflows. This article explains how proofreading PCR can strengthen assay architecture around the bufalin–CRISPR/Cas9 study while clarifying what PCR can—and cannot—demonstrate.

• Regorafenib Promotes Melanoma Control Through RRM2

  2026-09-17

  A 2024 iScience study identifies RRM2 as a downstream mediator of Regorafenib activity in melanoma and links its reduction to disrupted ERK/E2F3 signaling. The work connects broad kinase inhibition with a testable molecular vulnerability, while providing a practical framework for studying melanoma growth, invasion, apoptosis, and tumor xenograft models.

• IWP-2 Workflow for Wnt Signaling Research

  2026-09-17

  Use IWP-2 as an upstream Wnt production inhibitor to connect pathway suppression with proliferation, migration, colony formation, and apoptosis readouts. This practical workflow combines PORCN-focused assay design with single-cell-inspired experimental controls, while clearly separating established evidence from exploratory applications.

• Betaine Hydrochloride for Translational Assays

  2026-09-16

  Betaine hydrochloride can support better-controlled biochemical and molecular biology workflows when its salt chemistry, solution stability, and matrix effects are considered explicitly. This article connects practical use of N1700 with the multi-endpoint inflammation framework reported in recent esophageal cancer research—without confusing assay support with therapeutic evidence.

• Z-WEHD-FMK: Reading the Pyroptosis Switch

  2026-09-16

  HOXC8-dependent suppression of caspase-1 reveals how transcriptional control can reshape pyroptotic fate in lung cancer. This thought-leadership analysis positions Z-WEHD-FMK as a practical causal probe for connecting inflammatory caspases with cancer biology, microbial pathogenesis, and translational assay design.

• NSP15 Inhibitor Screening: Thymopentin and Oleuropein

  2026-09-15

  The reference study used structure-based virtual screening and molecular dynamics to identify thymopentin and oleuropein as high-priority binders of the SARS-CoV-2 NSP15 endoribonuclease. Its main contribution is a computational framework for targeting viral immune evasion, while its predictions still require biochemical and cellular validation.

• Cucurbitacin I: From STAT3 Mechanism to Translation

  2026-09-15

  A translational framework for using Cucurbitacin I (JSI-124) to connect STAT3 target engagement with cancer phenotypes, in vivo tumor studies, and more physiologically organized research models.

• FITC-Concanavalin A (ConA) Conjugate Guide

  2026-09-14

  FITC-Concanavalin A (ConA) Conjugate, SKU K4413, provides direct fluorescent detection of accessible α-D-glucose and α-D-mannose structures on cells, tissues, and other glycobiology samples. It is suited to carbohydrate-focused immunofluorescence staining and flow cytometry, but it should not be treated as a probe for individual proteins or non-carbohydrate targets.

8542 records 1/570 page Next 12345 下5页 Last page